Glaxo CEO: Consumer health can stand on its own, but don’t expect a quick spinoff

Carly Helfand Lately, GlaxoSmithKline CEO Andrew Witty has seemed open to splitting off the industry-leading consumer health joint venture he formed with Novartis last year. But let ...

Glaxo weighs Qualcomm JV in quest to move ‘beyond the pill’

Carly Helfand Big Pharma companies–GlaxoSmithKline included–have been looking for ways to move "beyond the pill" to gain a technological leg up on their rivals. ...

Glaxo to reap $890M as it halves stake in South Africa’s Aspen

Carly Helfand Less than a year and a half ago, GlaxoSmithKline decided to sell off a chunk of its stake in fast-growing Aspen Pharmacare and reap the rewards from its investment. And ...

Glaxo layoffs continue as 27 Montana vaccine workers get the ax

Carly Helfand GlaxoSmithKline's job-chopping ax has struck Hamilton, MT, where 27 vaccine researchers will pack up this year. The pharma giant plans to centralize its R&D ...

FDA clears Glaxo Ebola vaccine for speedy human trials

Carly Helfand GlaxoSmithKline's vaccine candidate for the deadly Ebola virus is ready to roll in human trials. FiercePharma News

Glaxo seeks buyers for older products worth up to $12.6B

Carly Helfand GlaxoSmithKline has already made some moves to sell off some of its older meds. But now, it's making more that could end up much, much bigger. FiercePharma News

Xinhua: Multinationals, beware–or end up like Glaxo

Carly Helfand "Ethics matter" in China–and it's time for multinationals to take note, according to the country's official news agency. With a reputation-tarnishing ...

Sanofi, Glaxo sign up for vaccine R&D projects under new Gates initiative

John Carroll In its joint venture, Glaxo will front $ 1.8 million for work on the thermostability of vaccines. GSK will set out to make adjuvants–used to boost the effectiveness ...

Glaxo, Theravance Asthma Drug Elvar Ellipta OK’d in Japan

barbara.lempert ELVAR™ ELLIPTA™ Gains Approval in Japan for the Treatment of Asthma LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA–(Marketwired – Sep 20, ...

HHS Orders $196M in Anthrax Antitoxin From Glaxo

barbara.lempert HHS replenishes nation’s supply of anthrax antitoxin Contracts provide new surge capacity, maintain stockpile for public health emergencies The nation’s ...

A Glaxo Drug For A Type Of Muscular Dystrophy Is A Flop

esilverman In a blow to GlaxoSmithKline and a fledgling partner, the results of a Phase III study for a muscular dystrophy drug failed to meet its primary endpoint, a surprising ...

EU body endorses 11 new drugs from Glaxo, Roche, J&J and others

Ryan McBride A European Union regulator has recommended approval of 11 new drugs for a range of diseases such as HIV, breast cancer and diabetes. And the nods could lead to final approvals ...
Page 1 of 3123
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS